-
In November, a large number of pharmaceutical companies were fined, involving the production of inferior drugs and failing to correct problems
Time of Update: 2023-01-01
Since the implementation of the new version of the Drug Administration Law, industry supervision has become stricter, and relevant departments have repeatedly struck hard to strictly investigate whether the production and operation behavior of pharmaceutical companies complies with the regulations, and in this context, many pharmaceutical companies have been fined for the production and sale of counterfeit drugs, environmental protection, and failure to correct problems.
-
List of Prohibitions on Online Sales of Drugs (Draft for Solicitation of Comments
Time of Update: 2022-11-15
Feedback form Comprehensive Department of the State Food and Drug Administration November 2, 2022 List of Prohibitions on Online Sales of Drugs (Draft for Solicitation of Comments) (First Edition) (Established in November 2022)
-
The Ministry of Ecology and Environment and the Ministry of Emergency Management signed an agreement to establish an emergency linkage working mechanism for ecological and environmental emergencies
Time of Update: 2022-11-15
On November 4, the Ministry of Ecology and Environment and the Ministry of Emergency Management signed the Agreement on the Establishment of an Emergency Linkage Working Mechanism for Ecological and E
-
Effects of lotus seed resistant starch and sodium lactate on small intestinal flora and metabolites in rats
Time of Update: 2022-10-31
The small intestine is an important place for human digestion and absorption, mainly through enzymes to act on sugar, cholesterol, protein and other nutrients, the number of small intestinal microorga
-
Recently, the field of diabetes has ushered in a number of blockbuster new drugs
Time of Update: 2022-09-21
According to the China Drug Clinical Trial Registration and Information Publicity Platform, Eli Lilly has conducted five related clinical trials in China, in addition to the completed clinical trial of type 2 diabetes, there are three ongoing international multicenter Phase 3 clinical trials, the indications are obstructive sleep apnea and obesity, overweight/obesity, and reducing the compound outcomes of major adverse cardiovascular events in patients with type 2 diabetes mellitus with an increased risk of cardiovascular disease.
-
Effect of cellular metabolites on tumors
Time of Update: 2022-09-15
▲Metabolic pathways in the tumor microenvironment and their effects on the function of anti-tumor immune cells (Image source: Reference source 1)brief summaryMethods that target tumor cell or immune cell metabolism can work synergistically with immunotherapy, and utilizing metabolic pathways in TME may increase the lower response rates of current immunotherapies.
-
Huaian Hongze District Municipal Supervision Bureau takes four measures to ensure food safety in the district
Time of Update: 2022-09-13
Carry out a comprehensive inventory and filing of food business households, innovate the implementation of the regional supervision responsibility system, assign responsibilities to people, and conduct serious daily assessments to ensure that the work is promoted and the food safety line of defense is firmly guarded .
-
Jiangsu Shuyang County Market Supervision Bureau Cross Branch "five in place" to protect campus food safety
Time of Update: 2022-08-30
In order to ensure that the majority of teachers and students can eat with peace of mind, the Cross Branch of the Market Supervision Bureau of Shuyang County, Jiangsu Province has normalized food saf
-
What are the commonly used labeling methods for labeling machines
Time of Update: 2022-06-03
This is a technology that needs to maintain continuous operation, so its labeling efficiency is improved, and it is mostly suitable for high-speed and high-speed automatic packaging production lines .
-
Sun Lei, Director of the Device Review Center: Promote the reform of the medical device review and approval system in depth
Time of Update: 2022-05-30
The Medical Device Technology Review Center of the State Food and Drug Administration (hereinafter referred to as the Device Review Center) carefully plans, establishes rules and regulations, and makes solid progress, optimizes the review process, standardizes review work, implements review science, and continuously improves review quality and efficiency.
-
The mechanism of super biofilm formation caused by the deletion of a small fragment of the methylated chemotactic receptor protein WspA in Pseudomonas aeruginosa revealed by the Institute
Time of Update: 2022-05-12
In summary, this study revealed the mechanism by which the methylated chemotactic receptor protein WspA activates the synthesis of cyclic-di-GMP through the loss of small fragments, thereby leading to the formation of super biofilms in strains, which is related to the prevention and control of super biofilms.
-
Another successful pharmaceutical company: rich R&D pipelines, half of the funds raised are planned to be used for new drug R&D
Time of Update: 2022-05-11
The listing of Nuocheng Jianhua on the Science and Technology Innovation Board plans to raise 4 billion yuan, of which half of the funds will be used for new drug research and development .
-
The Chinese medicine market has opened up, and institutions have been investigating
Time of Update: 2022-04-15
For example, Zhenbao Island stated in its investor relations activity record sheet released on March 29 that the company accepted four institutional surveys on March 25, 2022, with the types of institutions being insurance companies, fund companies, and securities companies .
-
Target PD-L1
Time of Update: 2022-03-09
According to public information, RO7191863 is a liver-directed, PD-L1-targeting N-acetylgalactosamine (GalNac)-modified single-stranded oligonucleotide candidate drug, which is planned to be developed for the treatment of chronic hepatitis B.
-
Notice of the State Food and Drug Administration on Issuing the Catalogue of Generic Drug Reference Preparations (Fifty Batch) (No. 9, 2022
Time of Update: 2022-03-02
Notice of the State Food and Drug Administration on Issuing the Catalogue of Generic Drug Reference Preparations (Fifty Batch) (No.
Attachment: Catalogue of Generic Drug Reference Preparations (Fifty Batch) State Food and Drug Administration February 10, 2022 Relevant attachments serial number accessory name 1 Annex to the Circular No.
